(Q38147399)

29 August 2017

Inhibitors of cathepsin G: a patent review (2005 to present). (English)

1 reference

29 August 2017

Paulina Kosikowska

1

0 references

Adam Lesner

series ordinal

2

object named as

Adam Lesner

1 reference

PubMed ID

24079661

29 August 2017

language of work or name

English

0 references

publication date

30 September 2013

1 reference

Expert Opinion on Therapeutic Patents

29 August 2017

1 reference

29 August 2017

23

1 reference

29 August 2017

12

1 reference

29 August 2017

1611-1624

1 reference

Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

NSP4, an elastase-related protease in human neutrophils with arginine specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Proteases and lymphocyte cytotoxic killing mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Structure and evolutionary origin of the human granzyme H gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human alpha/delta T-cell receptor locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

The role of the renin-angiotensin system in aortic aneurysmal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Size and location of thrombus in intact and ruptured abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

SerpinB1 is critical for neutrophil survival through cell-autonomous inhibition of cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

The role of neutrophilic secretion products in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

The cathepsin family and their role in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Structural basis of the endoproteinase-protein inhibitor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Canonical protein inhibitors of serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

A tick salivary protein targets cathepsin G and chymase and inhibits host inflammation and platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Metallo-aminopeptidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Phosphonic esters and their application of protease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

New potent cathepsin G phosphonate inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Urease inhibitory activities of β-boswellic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Acetyl-keto-β-boswellic acid induces lipolysis in mature adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

In vitro and in vivo inhibitory activities of four Indian medicinal plant extracts and their major components on rat aldose reductase and generation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Heparin accelerates the inhibition of cathepsin G by mucus proteinase inhibitor: potent effect of O-butyrylated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Inhibition of leucocyte elastase by heparin and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Methods for selection of aptamers to protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.835397

10.1517/13543776.2013.835397

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

24079661